Rani Therapeutics Holdings Inc Class A
Research Rani Therapeutics Holdings Inc Class A (RANI) on Bullrun: market cap USD 100.24M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerRANI
- ExchangeNASDAQ
- CountryUnited States
- SectorHealthcare
- IndustryBiotechnology
- CurrencyUSD
- Market capUSD 100.24M
- Financial periodQ1 2026
- RevenueUSD 1.71M
- Net income-USD 7.03M
- Free cash flow-USD 6.51M
Valuation Snapshot
latest market cap is USD 100.24M.
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | USD 1.63M | -USD 29.67M | -USD 18.80M | n/a | -0.45 | USD 18.62M | USD 0 | USD 33.01M |
| FY2024 | USD 1.03M | -USD 30.02M | -USD 35.76M | n/a | -1.05 | USD 3.76M | USD 24.61M | USD 1.99M |
| FY2023 | USD 0 | -USD 33.97M | -USD 52.47M | n/a | -1.33 | USD 5.86M | USD 29.38M | USD 12.87M |
| FY2022 | USD 0 | -USD 30.59M | -USD 48.13M | n/a | -1.28 | USD 27.01M | USD 29.15M | USD 36.86M |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-08-25 | USD 100.24M | n/a | n/a | n/a |
| 2025 | 2025-12-31 | USD 131.79M | n/a | n/a | n/a |
| 2024 | 2024-12-31 | USD 45.80M | n/a | n/a | n/a |
| 2023 | 2023-12-29 | USD 85.92M | n/a | n/a | n/a |
| 2022 | 2022-12-30 | USD 145.85M | n/a | n/a | n/a |
| 2021 | 2021-12-31 | USD 322.29M | n/a | n/a | n/a |
About Rani Therapeutics Holdings Inc Class A
Rani Therapeutics Holdings, Inc. operates as a clinical stage biotherapeutics company, focusing on technologies to enable the administration of biologics and drugs orally for patients, physicians, and healthcare systems with a alternative to painful injections in the United States. The company develops the RaniPill capsule, a drug-agnostic oral delivery platform to deliver a variety of drug substances, including oligonucleotides, peptides, proteins, and antibodies.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Rani Therapeutics Holdings Inc Class A's market cap?
Rani Therapeutics Holdings Inc Class A's market capitalization is USD 100.24M.
What does Rani Therapeutics Holdings Inc Class A do?
Rani Therapeutics Holdings, Inc. operates as a clinical stage biotherapeutics company, focusing on technologies to enable the administration of biologics and drugs orally for patients, physicians, and healthcare systems with a alternative to painful injections in the United States. The company develops the RaniPill capsule, a drug-agnostic oral delivery platform to deliver a variety of drug substances, including oligonucleotides, peptides, proteins, and antibodies.